| Mirtazapine | |
|---|---|
| Salts [] | |
|---|---|
| Mirtazapine hemihemihydrate | |
| Mirtazapine hydrobromide | |
| Mirtazapine hydrochloride | |
| Molecular structure via molpic based on CDK |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 265.35 g/mol [1] |
| Melting point | 114-116 °C [1] |
| Solubility | slightly soluble in water [1] |
| Predicted LogP | 3.3 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C17H19N3 [1] |
| IUPAC name | 5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene [1] |
| SMILES | CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4 [1] |
| InChI | InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3 [1] |
| InChIKey | RONZAEMNMFQXRA-UHFFFAOYSA-N [1] |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 20 – 40 hours |
Mirtazapine
Mirtazapine (also known as Mirtazapine, 85650-52-8, Remeron, Mepirzepine, 6-Azamianserin, Remergon, Zispin, Promyrtil, Remergil or Rexer) is a
Chemistry
Salts []
Mirtazapine is typically found in the form of its hemihemihydrate, hydrobromide and hydrochloride salts.
Stereochemistry []
Mirtazapine is a racemic mixture of the enantiomers
Legal status []
- Australia: Mirtazapine is a S4 substance.
- Brazil: Mirtazapine is a C1 substance.[3]
- Canada: Mirtazapine is a prescription only substance.
- United Kingdom: Mirtazapine is a prescription only substance.
- United States: Mirtazapine is a prescription only substance.
- European Union: Mirtazapine is a prescription only substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 4205, Mirtazapine. Accessed January 2, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/4205
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Mirtazapine. UNII: A051Q2099Q. Global Substance Registration System. Accessed January 2, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/A051Q2099Q
Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. March 31, 2023. Accessed January 2, 2026. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992